add_icon

J B Chemicals and Pharmaceuticals

2,005.40
+35.20
(1.79%)
Market Cap
32,198.44 Cr
PE Ratio
41.97
Volume
3,36,850.00
Day High - Low
2,009.00 - 1,968.40
52W High-Low
2,195.00 - 1,494.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
32,198.44 Cr
EPS
42.45
PE Ratio
41.97
PB Ratio
8.31
Book Value
237.06
EBITDA
1,070.20
Dividend Yield
0.76 %
Industry
Healthcare
Return on Equity
19.21
Debt to Equity
0.06
Forecast For
Actual

Company News

View All News
Caret
neutral
J. B. Chemicals & Pharmaceuticals Limited submits mandatory quarterly certificate under SEBI Depositories Regulations for quarter ended March 31, 2026, confirming proper dematerialization procedures.
neutral
J.B. Chemicals & Pharmaceuticals announces cessation of Nikhil Chopra as CEO and Key Managerial Personnel effective March 31, 2026, following his resignation for personal reasons and new opportunities.
neutral
J.B. Chemicals published newspaper advertisement for equity shareholder meeting on April 28, 2026, convened pursuant to NCLT order dated March 23, 2026 for Torrent Pharmaceuticals merger approval.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,654.90
#1 3,97,065.94
37.62
#1 54,729.00
9.71
#1 10,980
16.07
34.03
6,116.50
1,62,373.86
63.80
9,712.00
18.67
2,191
-1.02
53.67
4,155.20
1,40,630.85
60.97
11,539.40
6.99
1,911
26.24
47.83
2,333.80
1,06,664.75
22.48
22,909.50
13.74
3,306
#1 37.44
57.51
1,232.20
1,02,844.71
18.32
33,741.20
16.73
5,725
-15.28
45.58
1,229.50
99,316.63
21.81
28,409.50
7.12
5,291
-57.18
40.75
915.40
92,110.66
#1 18.06
23,511.00
18.55
4,615
-0.32
57.32
2,079.00
85,822.17
47.03
12,744.20
#1 20.90
2,007
7.65
51.63
1,349.40
78,373.37
22.33
32,345.60
9.43
3,484
7.59
65.82
5,440.00
65,043.36
26.50
13,458.30
3.70
2,216
1.90
53.68

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
12.35 %
Net Income Growth
19.36 %
Cash Flow Change
12.72 %
ROE
1.64 %
ROCE
-3.02 %
EBITDA Margin (Avg.)
1.96 %

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 Apr 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
28 Apr 2026 2,082.50 2,005.40
22 Feb 2021 DIVIDEND Dividend
8.50 /share
18 Feb 2021 520.90 555.25
02 Sept 2021 DIVIDEND Dividend
8.00 /share
01 Sept 2021 770.03 850.15
24 Feb 2022 DIVIDEND Dividend
8.50 /share
23 Feb 2022 852.88 804.93
17 Aug 2022 DIVIDEND Dividend
8.00 /share
12 Aug 2022 785.18 931.68
18 Feb 2023 DIVIDEND Dividend
8.50 /share
17 Feb 2023 1,008.50 982.73
17 Aug 2023 DIVIDEND Dividend
9.25 /share
17 Aug 2023 976.00 1,315.08
24 May 2023 SPLIT Split
1:2
18 Sept 2023 976.00 976.00
16 Feb 2024 DIVIDEND Dividend
5.50 /share
16 Feb 2024 1,708.40 1,664.30
14 Aug 2024 DIVIDEND Dividend
6.75 /share
14 Aug 2024 1,832.55 1,941.60
21 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Aug 2024 1,788.80 1,942.60
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 1,895.75 1,852.00
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 1,805.05 1,714.10
08 Feb 2025 DIVIDEND Dividend
8.50 /share
07 Feb 2025 1,714.10 1,673.75
14 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 May 2025 1,658.70 1,579.85
30 Jul 2025 DIVIDEND Dividend
7.00 /share
30 Jul 2025 1,579.85 1,802.60
30 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jul 2025 1,651.85 1,802.60
06 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Aug 2025 1,612.55 1,692.45
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 1,708.80 1,813.40
16 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 Jan 2026 1,818.60 1,894.20
11 Feb 2026 DIVIDEND Dividend
12.70 /share
11 Feb 2026 1,893.35 1,923.55

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
-100000
-3.64%
-3.43%
Helios Mid Cap Fund Direct-Growth
0.00%
-99780
-1.67%
-1.59%
Helios Small Cap Fund Direct-Growth
0.00%
-60190
-1.71%
-1.72%
ICICI Prudential Quality Fund Direct-Growth
0.00%
-51171
-0.46%
-0.42%
Capitalmind Flexi Cap Fund Direct-Growth
1.97%
35588
1.97%
1.97%
Bandhan Healthcare Fund Direct-Growth
4.91%
-15000
-0.66%
-0.44%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-11160
-0.88%
-0.80%
PGIM India Multi Asset Allocation Fund Direct-Growth
0.00%
-11053
-0.92%
-0.90%
ITI Business Cycle Fund Direct-Growth
1.57%
7051
1.57%
1.57%
WhiteOak Capital Consumption Opportunities Fund Direct-Growth
1.91%
-1107
-0.09%
1.91%
DSP Nifty500 Flexicap Quality 30 Index Fund Direct-Growth
1.68%
-1033
-0.36%
-0.07%
JioBlackRock Sector Rotation Fund Direct-Growth
0.00%
-687
-0.13%
0.00%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.00%
-145
-0.29%
-0.27%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.33%
43
0.03%
0.33%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.98%
-38
0.10%
0.18%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.10%
13
0.01%
0.02%
DSP Nifty 500 Index Fund Direct-Growth
0.09%
6
0.00%
0.01%
Kotak Aggressive Hybrid Fund Direct-Growth
0.88%
0
0.00%
0.09%
Axis Multicap Fund Direct-Growth
0.82%
0
0.00%
0.08%
Axis Value Fund Direct-Growth
0.89%
0
0.00%
0.07%
Bandhan Balanced Advantage Fund Direct-Growth
0.18%
0
0.00%
0.02%
Bandhan BSE Healthcare Index Fund Direct-Growth
1.31%
0
0.00%
0.08%
Bandhan Focused Fund Direct-Growth
1.42%
0
0.00%
-0.31%
Axis Retirement Fund - Conservative Plan Direct-Growth
1.05%
0
0.00%
0.07%
Bandhan Multi Asset Allocation Fund Direct-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
41.32
ATR(14)
Less Volatile
59.75
STOCH(9,6)
Neutral
22.91
STOCH RSI(14)
Oversold
8.33
MACD(12,26)
Bearish
-20.75
ADX(14)
Weak Trend
23.83
UO(9)
Bearish
47.46
ROC(12)
Downtrend And Accelerating
-5.50
WillR(14)
Neutral
-74.34

About J B Chemicals and Pharmaceuticals

J.B. Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1976. It manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. The company specializes in gastroenterology, hypertension, and dermatology, with additional focus on nephrology, respiratory, virology, diabetes, and nicotine replacement therapy. Key brands...more
Chairperson NameArun Duggal